| abstract |
The present invention relates to substituted benzoxazole and benzofuran chemical entities of formula (I): wherein V, W, X, Y, Z and m have any of the values described in the description and compositions comprising such entities. chemical; their manufacturing processes; and their use in a wide range of processes, including kinetic metabolic and reaction studies; detection and imaging techniques; radioactive treatments; and treating one or more disorders, including neurological, cognitive, immunological, and inflammatory disorders, as well as other disease states and diseases involving PDE7 or cyclic nucleotide signaling. |